Literature DB >> 3438882

Hyaluronic acid in bronchoalveolar lavage fluid in patients with sarcoidosis: relationship to lavage mast cells.

L Bjermer1, A Engström-Laurent, M Thunell, R Hällgren.   

Abstract

Hyaluronate (hyaluronic acid), a potential marker for activated pulmonary fibroblasts, appears in increased concentrations in bronchoalveolar lavage fluid from patients with sarcoidosis. The mechanisms underlying fibroblast proliferation are largely unknown but activated alveolar T lymphocytes and macrophages probably play a part; the mast cell is also important for fibroblast proliferation. This study was designed to determine whether there is any association between pulmonary mast cells in lavage fluid, which are known to be increased in patients with sarcoidosis, and signs of pulmonary fibroblast activation. A strong correlation was found between lavage fluid hyaluronate and recovered mast cells (r = 0.72, p less than 0.001). Moreover, mast cell and hyaluronate estimations correlated inversely with lung volume and transfer factor for carbon monoxide, and both indices increased with advancing radiological sarcoid stage. Macrophage and granulocyte counts were normal in lavage fluid from patients with sarcoidosis and were not related to lavage fluid hyaluronate or laboratory signs of the disease in the lungs. Lymphocytes were recovered in increased numbers (p less than 0.001) and were related to the lavage fluid mast cells and hyaluronate. It is concluded that in sarcoidosis release of hyaluronate into the airways is related to the degree of lung disease and to the local inflammatory reaction in the lung as defined by increased numbers of mast cells and lymphocytes in lavage fluid. The findings may reflect a link between the immune system, activation of mast cells, and a pulmonary fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3438882      PMCID: PMC461053          DOI: 10.1136/thx.42.12.933

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  31 in total

1.  Mast cells and lysozyme positive macrophages in bronchoalveolar lavage from patients with sarcoidosis. Valuable prognostic and activity marking parameters of disease?

Authors:  L Bjermer; O Bäck; G Roos; M Thunell
Journal:  Acta Med Scand       Date:  1986

2.  Mast cells in the rat alveolar septa undergoing fibrosis after ionizing irradiation. Ultrastructural and histochemical studies.

Authors:  S Watanabe; K Watanabe; T Oishi; M Aiba; K Kageyama
Journal:  Lab Invest       Date:  1974-11       Impact factor: 5.662

3.  Glycosaminoglycans of bovine lung parenchyma and pleura.

Authors:  F S Wusteman
Journal:  Experientia       Date:  1972-08-15

4.  Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats.

Authors:  T Goto; D Befus; R Low; J Bienenstock
Journal:  Am Rev Respir Dis       Date:  1984-11

5.  The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue.

Authors:  J D Russel; S B Russell; K M Trupin
Journal:  J Cell Physiol       Date:  1977-12       Impact factor: 6.384

6.  Concentration of sodium hyaluronate in serum.

Authors:  A Engström-Laurent; U B Laurent; K Lilja; T C Laurent
Journal:  Scand J Clin Lab Invest       Date:  1985-10       Impact factor: 1.713

7.  Interrelationship between stimulation of prostaglandin E and hyaluronate production by poly (I) . poly (C) and interferon in synovial fibroblast culture.

Authors:  M Yaron; I Yaron; C Wiletzki; U Zor
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

8.  Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells?

Authors:  A Engström-Laurent; N Feltelius; R Hällgren; A Wasteson
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

9.  Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease.

Authors:  R Hällgren; A Eklund; A Engström-Laurent; B Schmekel
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

10.  Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases.

Authors:  P L Haslam; A Dewar; P Butchers; Z S Primett; A Newman-Taylor; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1987-01
View more
  6 in total

1.  Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep.

Authors:  A M Cantin; P Larivée; M Martel; R Bégin
Journal:  Lung       Date:  1992       Impact factor: 2.584

2.  Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.

Authors:  L Bjermer; R Lundgren; R Hällgren
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

3.  Predictive value of bronchoalveolar lavage cell analysis in sarcoidosis.

Authors:  L Bjermer; L Rosenhall; T Angström; R Hällgren
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

4.  Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis.

Authors:  S Kullberg; N V Rivera; M Abo Al Hayja; J Grunewald; A Eklund
Journal:  Clin Exp Immunol       Date:  2020-04-22       Impact factor: 4.330

Review 5.  Densification: Hyaluronan Aggregation in Different Human Organs.

Authors:  Antonio Stecco; Mary Cowman; Nina Pirri; Preeti Raghavan; Carmelo Pirri
Journal:  Bioengineering (Basel)       Date:  2022-04-05

Review 6.  The Rise and Fall of Hyaluronan in Respiratory Diseases.

Authors:  Mark E Lauer; Raed A Dweik; Stavros Garantziotis; Mark A Aronica
Journal:  Int J Cell Biol       Date:  2015-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.